This study looks at two different treatments for people with advanced nonsquamous non-small cell lung cancer. The goal is to see how well sotorasib combined with chemotherapy works compared to pembrolizumab with chemotherapy. Both treatments are being tested to find out which helps patients live longer without their cancer getting worse.
This study is registered under NCT05920356. It is a Phase 3 trial, which means researchers are looking at how well the treatments work and how safe they are. About 750 participants are expected to join this trial, which is regulated by the FDA.
Who can join
Adults aged 18 to 100 can join. This trial is for people diagnosed with advanced stage IV or stage IIIB/C nonsquamous non-small cell lung cancer. Participants should have a specific mutation called KRAS p.G12C and cannot have received previous treatments for their cancer. Some people may not be able to join if they have certain types of tumors or health issues. The trial team confirms who can participate.
Condition
Non-Small Cell Lung Cancer (NSCLC)
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly placed into one of two groups. One group will receive sotorasib along with carboplatin and pemetrexed. The other group will receive pembrolizumab along with carboplatin and pemetrexed. Everyone in the trial will get treatment, but the specific treatment depends on the group they are in.
Where
This trial is enrolling at 21 locations. Recruiting sites are listed first.
Alliance Cancer Specialists - Media
Media, Pennsylvania
Recruiting
Duke University Medical Center
Durham, North Carolina
Recruiting
FirstHealth Cancer Center
Pinehurst, North Carolina
Recruiting
Illinois Cancer Specialists
Niles, Illinois
Recruiting
Medical Oncology Hematology Consultants Helen F Graham Cancer Center
Chief of Thoracic Surgery and Director of the Lung Cancer Program at West Virginia University Cancer Institute. Treats lung cancer and esophageal cancer.
Treats pancreatic cancer, lung cancer and colorectal cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Led the National Lung Screening Trial. Treats lung cancer. Other doctors who help with cancer care, like gastroenterologists, dermatologists, and endocrinologists. Recognized at state, national or international level.